Evidence map›Paper›PMID 41599676›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Losartan Protects Against Radiation-Induced Testicular Damage by Modulating Oxidative Stress, Testosterone Levels, and Metabolic Profile.

Maria A Spadella, Rúben J Moreira, Patrícia C Braga, Agnaldo B Chies, Pedro F Oliveira, Marco G Alves

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria A SpadellaHuman Embryology Laboratory, Marília Medical School, Marilia 17519-030, SP, Brazil.ORCID 0000-0002-9843-0169
Rúben J MoreiraInstitute of Biomedicine, Department of Medical Science (iBiMED), University of Aveiro, 3010-193 Aveiro, Portugal.ORCID 0009-0008-9130-5809
Patrícia C BragaUnit for Multidisciplinary Research in Biomedicine (UMIB), Institute of Biomedical Sciences Abel Salazar (ICBAS), 4050-313 Porto, Portugal.ORCID 0000-0002-3813-8107
Agnaldo B ChiesLaboratory of Pharmacology, Marília Medical School, Marilia 17519-030, SP, Brazil.ORCID 0000-0001-9263-2475
Pedro F OliveiraLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3010-193 Aveiro, Portugal.ORCID 0000-0002-4989-5699
Marco G AlvesInstitute of Biomedicine, Department of Medical Science (iBiMED), University of Aveiro, 3010-193 Aveiro, Portugal.ORCID 0000-0001-7635-783X

Funding

FCT-Fundação para a Ciência e a Tecnologia 2024.03012.BDFCT-Fundação para a Ciência e a Tecnologia CEEC-INST/00026/2018FCT-Fundação para a Ciência e a Tecnologia UID/50006/2025FCT-Fundação para a Ciência e a Tecnologia UIDB/04501/2020FCT-Fundação para a Ciência e a Tecnologia UIDP/04501/2020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiotensin receptor blockerlosartanradioprotectorradiotherapyrenin-angiotensin systemspermatogenesis

Identifiers

PMID41599676
PMCPMC12845136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.